<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283519/" ref="ordinalpos=3988&amp;ncbi_uid=7078999&amp;link_uid=PMC4283519" image-link="/pmc/articles/PMC4283519/figure/F1/" class="imagepopup">Figure 1.  From: Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation. </a></div><br /><div class="p4l_captionBody"><b>Signaling pathway interaction and effects of modulators:</b> cGMP and cAMP-dependent intracellular signaling systems in the insulin-mediated regulation of platelet aggregation in patients with metabolic disorders.</div></div>